Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $1000.0.

  • Medifast's Cash from Financing Activities rose 20000.0% to $1000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$564000.0, marking a year-over-year increase of 6277.23%. This contributed to the annual value of -$564000.0 for FY2025, which is 6277.23% up from last year.
  • Latest data reveals that Medifast reported Cash from Financing Activities of $1000.0 as of Q4 2025, which was up 20000.0% from -$2000.0 recorded in Q2 2025.
  • Over the past 5 years, Medifast's Cash from Financing Activities peaked at $1000.0 during Q4 2025, and registered a low of -$102.0 million during Q2 2022.
  • Its 5-year average for Cash from Financing Activities is -$21.4 million, with a median of -$18.2 million in 2023.
  • Per our database at Business Quant, Medifast's Cash from Financing Activities tumbled by 25501.77% in 2022 and then soared by 20000.0% in 2025.
  • Medifast's Cash from Financing Activities (Quarter) stood at -$31.2 million in 2021, then increased by 22.1% to -$24.3 million in 2022, then rose by 26.41% to -$17.9 million in 2023, then surged by 99.99% to -$1000.0 in 2024, then surged by 200.0% to $1000.0 in 2025.
  • Its Cash from Financing Activities stands at $1000.0 for Q4 2025, versus -$2000.0 for Q2 2025 and -$563000.0 for Q1 2025.